Rifamycin b diethylamide
- Level
- Commodity
- Parent
- 51283600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51283608This classification denotes an antitubercular agent with the molecular formula C43H58N2O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TS121H7U7E, chemically known as rifamycin, 4-o-(2-(diethylamino)-2-oxoethyl)-, but more generally known as rifamycin b diethylamide, which bears US NIH Compound Identifier 5382104. European Medicines Agency schedules rifamycin b diethylamide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10310MIG. Most nations, for tariff purposes, schedule rifamycin b diethylamide under HS 29419000. SMILES: CCN(CC)C(=O)COC1CC2C(C3C1C4C(C(C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(=O)N2)/C)C)O)C)O)C)OC(=O)C)C)OC)C)O.
Same parent
Under 51283600 · 12Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.